Aditya Birla Sun Life Mutual Fund launches Aditya Birla Sun Life Pharma & Healthcare Fund
NFO period: 20th June – 04th July, 2019
Highlights of the NFO:
- Scheme type – An open ended equity scheme investing in Pharma and Healthcare Services Sector
- Investment objective – The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
- Product suitability – The product is suitable for investors who are seeking long term capital growth by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
- Minimum Application Amount – First investment is Rs. 1,000/- and in multiples of Rs. 1/- thereafter
- Plan/ Options available – Regular Plan and Direct Plan having Growth Option and Dividend Option (Payout & Reinvestment Facility).
- Fund Manager – Mr. Dhaval Shah
- Benchmark – S&P BSE Healthcare TRI
(Mutual Fund investments are subject to market risks, read all scheme related documents carefully.)